Electronic Journal of General Medicine

• Bousquet J, Dhivert H, Michel FB. Current trends in the management of allergic diseases. Allergy 1994;94:31-6
• BSACI Working Party on Allergen Immunotherapy. Position Paper. Clin Exp Allergy 1993;23:32-5
• Casale TB. Status of immunotherapy: current and future. J Allergy Clin Immunol 2004;113: 1036-39
• Gulen F, Zeyrek D, Can D, et al. Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. Asian Pac J Allergy Immunol 2007;25:7-11
• Huggins JL, Looney RJ. Allergen immunotherapy. Am Fam Physician 2004;70: 689-96
• Kay AB, Holgate ST (eds): Position Paper on Allergen Immunotherapy, Report of a BSACI Working Party. Clin Exp Allergy 1993;(3):1-44
• Nuhoglu Y, Ozumut SS, Ozdemir C, Ozdemir M, Nuhoglu C, Erguven M. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period. J Investig Allergol Clin Immunol 2007;17(6): 375-78
• Robinson DS. Allergen immunotherapy: Does it work and, if so, how and for how long? Thorax 2000;55:11-4
• World Health Paper, an executive summary. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Ann Allergy Asthma Immunol 1998;81:401-5
• X Yang. Does Allergen Immunotherapy Alter the Natural Course of Allergic Disorders? Drugs 2001;61(3): 365-74
• Bonifazi F, Bilo MB. Efficacy of specific immunotherapy in allergic asthma: myth or reality? Allergy 1997;52:698-710
• Kowalski ML, Jutel M. Mechanisms of specific immunotherapy of allergic diseases. Allergy 1998;53:485-92
• Dreborg S, Agrell B, Foucard T, Kjellman NI, Koivikko A, Nilsson S. A doubleblind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation: 1. Clinical results. Allergy 1986;41(2):131-40
• Jacobsen L, Nuchel Petersen B, Wihl JA, Lowenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts: IV. Result from long-term (6 year) follow-up. Allergy 1997;52(9):914-20
• Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract: VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99(4):450-53
• Purello-D’Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001;31:1295-302
• Creticos PS, Norman PS: Immunotherapy with Allergens. JAMA 1987;258(20):2874-80
• Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass pollen immunotherapy. N Engl J Med 1999;341:468-75
• Mosbech H, Malling HJ, Biering I, et al Immunotherapy with yellow jacket venom: a comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy 1986;41:95-103
• Valentine MD. Insect venom allergy: diagnosis and treatment. J Allergy Clin Immunol 1984;73(3):299-304
• Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997;99:781-86
• Settipane RJ, Hagy GW, Settipane GA. Longterm risk factors for developing asthma and allergic rhinitis: a 23-year follow up study of college students. Allergy Proc 1994;15:21-5
• Djurup R. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy. Allergy 1985;40(7):469-86
• Oehling A, Sanz ML, Garcia BE. Immunological parameters in the immunotherapy follow-up. Int Arch Allergy Immunol 1992;99:474-77
• McHugh SM, Lavelle B, Kemeny DM, Patel S, Ewan PW. A Placebo-Controlled Trial of Immunotherapy with Two Extracts of Dermatophagoides Pteronyssinus in Allergic Rhinitis, Comparing Clinical Outcome with Changes in Antigen-Specific IgE, IgG, and IgG Subclasses. J Allergy Clin Immunol 1990;86:521-31
• Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18:263-66
• Crimi N, Li Gotti F, Mangano G, et al. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Ann Ital Med Int 2004;19(2):98- 108
• Vissers JL, van Esch BC, Hofman GA, Kapsenberg ML, Weller FR, van Oosterhout AJ. Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. J Allergy Clin Immunol 2004;113(6):1204-10
• Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103(6):779-88
• Nagata M, Tabe K, Hong Choo J, Sakamoto Y, Matsuo H. Effect of immunotherapy on the production of eosinophil adhesion-inducing activity from mononuclear cells in housedust-mite-sensitive bronchial asthma. Int Arch Allergy Immunol 1998;117:20-3
• Malling HJ, Weeke B. Immunotherapy EAACI Position Papers. Allergy 1993;48:9-35

Vancouver

Öztürk S, Çalıskaner AZ, Güleç M, Erel F, Kartal Ö, Karaayvaz M, et al. EFFECTS OF ALLERGEN SPECIFIC IMMUNOTHERAPY ON THE ALLERGENS EXCLUDED FROM THE TREATMENT. EUR J GEN MED. 2008;5(4):232-8. https://doi.org/10.29333/ejgm/82613

APA

Öztürk, S., Çalıskaner, A. Z., Güleç, M., Erel, F., Kartal, Ö., Karaayvaz, M., & Kutlu, A. (2008). EFFECTS OF ALLERGEN SPECIFIC IMMUNOTHERAPY ON THE ALLERGENS EXCLUDED FROM THE TREATMENT. European Journal of General Medicine, 5(4), 232-238. https://doi.org/10.29333/ejgm/82613

AMA

Öztürk S, Çalıskaner AZ, Güleç M, et al. EFFECTS OF ALLERGEN SPECIFIC IMMUNOTHERAPY ON THE ALLERGENS EXCLUDED FROM THE TREATMENT. EUR J GEN MED. 2008;5(4), 232-238. https://doi.org/10.29333/ejgm/82613

Chicago

Öztürk, Sami, Ahmet Z. Çalıskaner, Mustafa Güleç, Fuat Erel, Özgür Kartal, Mehmet Karaayvaz, and Ali Kutlu. "EFFECTS OF ALLERGEN SPECIFIC IMMUNOTHERAPY ON THE ALLERGENS EXCLUDED FROM THE TREATMENT". European Journal of General Medicine 2008 5 no. 4 (2008): 232-238. https://doi.org/10.29333/ejgm/82613

Harvard

Öztürk, S., Çalıskaner, A. Z., Güleç, M., Erel, F., Kartal, Ö., Karaayvaz, M., and Kutlu, A. (2008). EFFECTS OF ALLERGEN SPECIFIC IMMUNOTHERAPY ON THE ALLERGENS EXCLUDED FROM THE TREATMENT. European Journal of General Medicine, 5(4), pp. 232-238. https://doi.org/10.29333/ejgm/82613

MLA

Öztürk, Sami et al. "EFFECTS OF ALLERGEN SPECIFIC IMMUNOTHERAPY ON THE ALLERGENS EXCLUDED FROM THE TREATMENT". European Journal of General Medicine, vol. 5, no. 4, 2008, pp. 232-238. https://doi.org/10.29333/ejgm/82613